Role of regulatory elements and the MAPK/ERK or p38 MAPK pathways for activation of human cytomegalovirus gene expression

被引:23
|
作者
Chen, JP [1 ]
Stinski, MF [1 ]
机构
[1] Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA
关键词
D O I
10.1128/JVI.76.10.4873-4885.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A series of recombinant viruses with either site-specific mutations or various deletions of the early UL4 promoter of human cytomegalovirus were used to determine the roles of regulatory elements and the effects of the mitogen-activated protein kinase (MAPK) pathways. Viral gene expression was regulated by upstream cis-acting sites and by basic promoter elements that respond to the MAPK signal transduction pathways. Inhibitors of either the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway or the p38 MATK pathway affected expression equally with either wild-type or mutant early UL4 promoters in the viral genome, indicating that the effects of the inhibitors are not exclusive for a single transcription factor. The minimal responsive element is the TATA box-containing early viral promoter.
引用
收藏
页码:4873 / 4885
页数:13
相关论文
共 50 条
  • [21] p38 MAPK but not ERK is required for eosinophil migration and degranulation
    Shamri, Revital
    Young, Kristen
    Weller, Peter
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [22] p38 MAPK, Erk and Akt expression and activation in NSCLC tumors; Subcellular distribution and radiographic response to radiotherapy
    Tsakiridis, T
    Wright, J
    Vincic, L
    Junejo, M
    Tsiani, E
    Aljamad, H
    Sur, R
    Okawara, G
    Singh, G
    LUNG CANCER, 2005, 49 : S148 - S148
  • [23] Decrease of p38 MAPK activation in myeloproliferative disorders
    Shahjahan, M
    Dunphy, CH
    Singhal, N
    Garza, L
    Zu, Y
    Chang, C
    LABORATORY INVESTIGATION, 2006, 86 : 246A - 246A
  • [24] Decrease of p38 MAPK activation in myeloproliferative disorders
    Shahjahan, M
    Dunphy, CH
    Singhal, N
    Garza, L
    Zu, Y
    Chang, C
    MODERN PATHOLOGY, 2006, 19 : 246A - 246A
  • [25] Activation of p38 MAPK is not a trigger for ischaemic preconditioning
    Genade, S
    Marais, E
    Moolman, J
    Lochner, A
    EUROPEAN HEART JOURNAL, 2002, 23 : 244 - 244
  • [26] Substance P Enhances Chemokine Expression in Murine Macrophages via ERK/p38 MAPK-NF-κB Pathways
    Jia, Sun
    Ramnath, Raina
    Bhatia, Madhav
    FASEB JOURNAL, 2008, 22
  • [27] CTGF Is Increased in Basal Deposits and Regulates Matrix Production through the ERK (p42/p44mapk) MAPK and the p38 MAPK Signaling Pathways
    Nagai, Norihiro
    Klimava, Alena
    Lee, Wen-Hsiang
    Izumi-Nagai, Kanako
    Handa, James T.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (04) : 1903 - 1910
  • [28] LDL INCREASES VASCULAR ETB2 RECEPTOR EXPRESSION VIA ACTIVATION OF ERK1/2 AND P38 MAPK PATHWAYS
    Zhang, Y.
    Zheng, J. -P.
    Zhang, W.
    Edvinsson, L.
    Xu, C. -B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 94 - 95
  • [29] Activation of ERK 1/2 and p38 MAPK during Reperfusion in Human and Rat Kidney Transplantation.
    Oellinger, Robert
    Rumberg, Guido
    Sucher, Robert
    Biebl, Matthias
    Kogler, Pamela
    Mark, Walter
    Margreiter, Raimund
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 576 - 576
  • [30] Differential role of PTK, ERK and p38 MAPK in superoxide impairment of NMDA cerebrovasodilation
    Philip, S
    Armstead, WM
    BRAIN RESEARCH, 2003, 979 (1-2) : 98 - 103